Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients.

Esteban Daudén, I Belinchón, E Colominas-González, P Coto, P de la Cueva, F Gallardo, J L Poveda, E Ramírez, S Ros, R Ruíz-Villaverde, M Comellas, Luís Lizán
Author Information
  1. Esteban Daudén: Department of Dermatology, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Hospital Universitario de La Princesa, Diego de León, 62, 28006, Madrid, Spain. estebandauden@gmail.com. ORCID
  2. I Belinchón: Department of Dermatology, Hospital General Universitario Dr Balmis-ISABIAL-UMH, Alicante, Spain. ORCID
  3. E Colominas-González: Department of Pharmacy, Hospital del Mar, Barcelona, Spain. ORCID
  4. P Coto: Department of Dermatology, Hospital Vital Álvarez Buylla, Mieres, Spain.
  5. P de la Cueva: Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain. ORCID
  6. F Gallardo: Department of Dermatology, Hospital del Mar, Barcelona, Spain. ORCID
  7. J L Poveda: Department of Pharmacy, Hospital Universitario y Politécnico La Fe, Valencia, Spain. ORCID
  8. E Ramírez: Department of Pharmacy, Hospital Universitario de La Princesa, Madrid, Spain. ORCID
  9. S Ros: Departments of Dermatology and Rheumatology, and Cardiac Transplant Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. ORCID
  10. R Ruíz-Villaverde: Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain. ORCID
  11. M Comellas: Outcomes'10, Castellón de la Plana, Spain. ORCID
  12. Luís Lizán: Outcomes'10, Universidad Jaume I, Castellón de la Plana, Spain. ORCID

Abstract

Psoriasis is a chronic skin disease that negatively impacts on patient's life. A holistic approach integrating well-being assessment could improve disease management. Since a consensus definition of well-being in psoriasis is not available, we aim to achieve a multidisciplinary consensus on well-being definition and its components. A literature review and consultation with psoriasis patients facilitated the design of a two-round Delphi questionnaire targeting healthcare professionals and psoriasis patients. A total of 261 panellists (65.1% patients with psoriasis, 34.9% healthcare professionals) agreed on the dimensions and components that should integrate the concept of well-being: emotional dimension (78.9%) [stress (83.9%), mood disturbance (85.1%), body image (83.9%), stigma/shame (75.1%), self-esteem (77.4%) and coping/resilience (81.2%)], physical dimension (82.0%) [sleep quality (81.6%), pain/discomfort (80.8%), itching (83.5%), extracutaneous manifestations (82.8%), lesions in visible areas (84.3%), lesions in functional areas (85.8%), and sex life (78.2%)], social dimension (79.5%) [social relationships (80.8%), leisure/recreational activities (80.3%), support from family/friends (76.6%) and work/academic life (76.5%)], and satisfaction with disease management (78.5%) [treatment (78.2%), information received (75.6%) and medical care provided by the dermatologist (80.1%)]. This well-being definition reflects patients' needs and concerns. Therefore, addressing them in psoriasis will optimise management, contributing to better outcomes and restoring normalcy to the patient's life.

Keywords

References

  1. Psychiatr Pol. 2017 Dec 30;51(6):1145-1152 [PMID: 29432509]
  2. J Am Acad Dermatol. 2019 Apr;80(4):1073-1113 [PMID: 30772097]
  3. Actas Dermosifiliogr (Engl Ed). 2018 Oct;109(8):733-740 [PMID: 29970225]
  4. Postepy Dermatol Alergol. 2019 Aug;36(4):419-424 [PMID: 31616215]
  5. Psoriasis (Auckl). 2022 Jul 02;12:189-197 [PMID: 35813078]
  6. PLoS One. 2015 Aug 13;10(8):e0135162 [PMID: 26270647]
  7. Actas Dermosifiliogr. 2011 May;102(4):270-6 [PMID: 21333962]
  8. Clin Exp Dermatol. 2022 Jan;47(1):37-42 [PMID: 34160837]
  9. Int J Dermatol. 2018 Oct;57(10):1165-1172 [PMID: 29729012]
  10. Actas Dermosifiliogr (Engl Ed). 2019 Jan - Feb;110(1):12-19 [PMID: 30509759]
  11. J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1282-7 [PMID: 21241373]
  12. J Neurol. 2022 Dec;269(12):6269-6278 [PMID: 35945395]
  13. Psoriasis (Auckl). 2018 Dec 10;8:93-99 [PMID: 30574453]
  14. J Am Acad Dermatol. 2014 May;70(5):871-81.e1-30 [PMID: 24576585]
  15. J Clin Med. 2021 Feb 09;10(4): [PMID: 33572270]
  16. Front Immunol. 2021 Nov 15;12:715839 [PMID: 34867945]
  17. Actas Dermosifiliogr (Engl Ed). 2021 Mar;112(3):225-241 [PMID: 33065101]
  18. Eur J Public Health. 2015 Aug;25(4):731-40 [PMID: 25616594]
  19. Dtsch Arztebl Int. 2009 Jan;106(1-2):11-8, quiz 19 [PMID: 19564982]
  20. Br J Dermatol. 2020 Sep;183(3):548-558 [PMID: 31840228]
  21. Nature. 2012 Dec 20;492(7429):S62-3 [PMID: 23254976]
  22. Eur J Dermatol. 2014 Mar-Apr;24(2):224-8 [PMID: 24704621]
  23. J Psychosom Res. 2018 Nov;114:45-49 [PMID: 30314578]
  24. Br J Dermatol. 2004 Dec;151(6):1219-26 [PMID: 15606518]
  25. Acta Derm Venereol. 2020 Jan 30;100(3):adv00032 [PMID: 31971601]
  26. Acta Derm Venereol. 2010 May;90(3):257-63 [PMID: 20526542]
  27. Int J Dermatol. 2018 Nov;57(11):1275-1282 [PMID: 29516474]
  28. Actas Dermosifiliogr. 2013 Dec;104(10):897-903 [PMID: 24112536]
  29. J Eur Acad Dermatol Venereol. 2013 Feb;27(2):220-6 [PMID: 22329829]
  30. Indian Dermatol Online J. 2017 Sep-Oct;8(5):343-346 [PMID: 28979867]
  31. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):302-310 [PMID: 37822008]
  32. Health Qual Life Outcomes. 2020 Jun 19;18(1):192 [PMID: 32560725]
  33. J Eur Acad Dermatol Venereol. 2012 Jan;26(1):29-35 [PMID: 21385220]
  34. Arch Dermatol Res. 2018 May;310(4):271-319 [PMID: 29442137]
  35. Dermatol Ther (Heidelb). 2020 Apr;10(2):285-296 [PMID: 32146709]
  36. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1331-1339 [PMID: 31838769]
  37. Qual Life Res. 2016 Nov;25(11):2739-2754 [PMID: 27259580]
  38. J Clin Epidemiol. 2014 Apr;67(4):401-9 [PMID: 24581294]
  39. Sleep Med Rev. 2016 Oct;29:63-75 [PMID: 26624228]
  40. Dermatology. 2014;228(1):78-85 [PMID: 24434720]
  41. Acta Derm Venereol. 2019 Apr 1;99(4):417-422 [PMID: 30628634]
  42. Actas Dermosifiliogr. 2014 Mar;105(2):128-34 [PMID: 23668623]
  43. J Clin Med. 2022 May 16;11(10): [PMID: 35628929]
  44. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):403-412 [PMID: 34816508]

MeSH Term

Humans
Psoriasis
Health Personnel
Delphi Technique
Female
Male
Surveys and Questionnaires
Consensus
Adult
Quality of Life
Middle Aged
Self Concept

Word Cloud

Created with Highcharts 10.0.0lifewell-beingpsoriasispatients1%9%78]808%5%diseasemanagementconsensusdefinitionDelphihealthcareprofessionalsdimension832%6%Psoriasispatient'scomponents85758182lesionsareas3%76chronicskinnegativelyimpactsholisticapproachintegratingassessmentimproveSinceavailableaimachievemultidisciplinaryliteraturereviewconsultationfacilitateddesigntwo-roundquestionnairetargetingtotal261panellists6534agreeddimensionsintegrateconceptwell-being:emotional[stressmooddisturbancebodyimagestigma/shameself-esteem774%coping/resiliencephysical0%[sleepqualitypain/discomfortitchingextracutaneousmanifestationsvisible84functionalsexsocial79[socialrelationshipsleisure/recreationalactivitiessupportfamily/friendswork/academicsatisfaction[treatmentinformationreceivedmedicalcareprovideddermatologistreflectspatients'needsconcernsThereforeaddressingwilloptimisecontributingbetteroutcomesrestoringnormalcyDefiningpsoriasis:amongQualityWell-being

Similar Articles

Cited By

No available data.